President & Immunovant CEO
Mon, Oct 6, 2025
Oct 6
19,141 shares @ $3.85
Increased holdings by +1.20%
184th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
40% win rate · -0.8% median edge vs SPY (68 trades, 90-day)
Insider trade was 76% below market price
Price 42% above 200-day moving average